Quantitative magnetic resonance imaging assessment of muscle composition in myotonic dystrophy mice

[ad_1]

  • Johnson, NE et al. Population-based prevalence of myotonic dystrophy type 1 using statewide blood screening program genetic analysis. Neurology https://doi.org/10.1212/WNL.0000000000011425 (2021).

    Google Scholar article

  • Smith, CA & Gutmann, L. Management and therapeutics of myotonic dystrophy type 1. Fluent. To treat. Neurol options. 1852 (2016).

    Google Scholar article

  • Rossi, S. et al. Prevalence and predictive factors of respiratory failure in a large cohort of patients with myotonic dystrophy type 1 (DM1): retrospective and cross-sectional study. J. Neurol. Science. 399118-124 (2019).

    Google Scholar article

  • Hawkins, AM et al. Respiratory dysfunction in myotonic dystrophy type 1: a systematic review. Neuromuscular. Disorder. 29198-212 (2019).

    Google Scholar article

  • Ozimski, LL, Sabater-Arcis, M., Bargiela, A. & Artero, R. The characteristics of muscle dysfunction in myotonic dystrophy type 1. Biol. Round. https://doi.org/10.1111/brv.12674 (2020).

    Google Scholar article

  • Pettersson, OJ, Aagaard, L., Jensen, TG, and Damgaard, CK Molecular mechanisms in DM1 – A focus on foci. Nucleic Acids Res. https://doi.org/10.1093/nar/gkv029 (2015).

    Google Scholar article

  • Sergi, G., Trevisan, C., Veronese, N., Lucato, P. & Manzato, E. Imaging of sarcopenia. EUR. J. Radiol. 851519-1524 (2016).

    Google Scholar article

  • Sanz-Requena, R. et al. The role of imaging biomarkers in the assessment of sarcopenia. Diagnostic ten534 (2020).

    Google Scholar article

  • Díaz-Manera, J., Llauger, J., Gallardo, E. & Illa, I. Muscle MRI in muscular dystrophies. Acta Myol. 3495-108 (2015).

    Google Scholar

  • Carlier, PG et al. Quantitative nuclear magnetic resonance imaging and spectroscopy of skeletal muscle as an outcome measure for clinical trials. J. Neuromuscul. Say. 31–28 (2016).

    Google Scholar article

  • Mitchell, WK et al. Sarcopenia, dynapenia, and the impact of aging on human skeletal muscle size and strength; a quantitative report. Front. Physiol. https://doi.org/10.3389/fphys.2012.00260 (2012).

    Google Scholar article

  • Heskamp, ​​L. et al. Lower limb muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI. Neurology 92e2803–e2814 (2019).

    Google Scholar article

  • van der Plas, E. et al. Quantitative muscle MRI as a sensitive marker of early muscle pathology in myotonic dystrophy type 1. Muscular nerve 63553-562 (2021).

    Google Scholar article

  • Peric, S. et al. Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies. J. Neurol. 2641899-1908 (2017).

    Google Scholar article

  • Steenkjaer, CH, Mencagli, RA, Vaeggemose, M. & Andersen, H. Isokinetic strength and lower extremity muscle degeneration in patients with myotonic dystrophy; an MRI study. Neuromuscular. Disorder. 31198-211 (2021).

    Google Scholar article

  • Garibaldi, M. et al. Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): refining muscle involvement and its implications for clinical trials. EUR. J. Neurol. https://doi.org/10.1111/ene.15174 (2021).

    Google Scholar article

  • Pascual-Gilabert, M., López-Castel, A. & Artero, R. Drug development for myotonic dystrophy type 1: A pipeline to market. Drug discovery. Today 261765-1772 (2021).

    Google Scholar article

  • Mankodi, A. et al. Myotonic dystrophy in transgenic mice expressing an enlarged CUG repeat. Science 2891769-1773 (2000).

    Google Scholar Article Announcements

  • Mankodi, A. et al. Extended CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and skeletal muscle hyperexcitability in myotonic dystrophy. Mol. Cell ten35–44 (2002).

    Google Scholar article

  • Vihola, A. et al. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 601854–1857 (2003).

    Google Scholar article

  • Wei, C. et al. Correcting GSK3beta at a young age prevents muscle pathology in mice with myotonic dystrophy type 1. FASB J 322073-2085 (2018).

    Google Scholar article

  • Li, M. et al. Spliceopathy induced by HNRNPA1 in a transgenic mouse model of myotonic dystrophy. proc. Natl. Acad. Science. 1175472–5477 (2020).

    Google Scholar Article Announcements

  • Crawford Parks, TE, Marcellus, KA, Péladeau, C., Jasmin, BJ, and Ravel-Chapuis, A. Overexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features. Hmm. Mol. Broom. https://doi.org/10.1093/hmg/ddaa111 (2020).

    Google Scholar article

  • Carlier, PG & Reyngoudt, H. The growing role of MRI in neuromuscular disorders. Nat. Rev. Neurol. 16301–302 (2020).

    Google Scholar article

  • Park, D., Lee, S.-H., Shin, J.-H. & Park, J.-S. Magnetic resonance imaging of lower extremity muscles in myotonic dystrophy type 1 correlates with six-minute walk test and CTG repeats. Neuromuscular. Disorder. 2829-37 (2018).

    Google Scholar article

  • Perseghin, G. et al. Post-absorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1. A m. J. Clin. Nutr. 80357–364 (2004).

    Google Scholar article

  • Jones, K. et al. GSK3β mediates muscle pathology in myotonic dystrophy. J. Clin. Invest. https://doi.org/10.1172/JCI64081 (2012).

    Google Scholar article

  • Sabater-Arcis, M. et al. Musashi-2 contributes to muscle dysfunction in myotonic dystrophy by promoting excessive autophagy through repression of miR-7 biogenesis. Mol. The. Nucleic acids 25652–667 (2021).

    Google Scholar article

  • Sabater-Arcis, M., Bargiela, A., Furling, D. & Artero, R. miR-7 restores phenotypes in myotonic dystrophy muscle cells by repressing hyperactivated autophagy. Mol. The. Nucleic acid 19278-292 (2020).

    Google Scholar article

  • Loro, E. et al. Normal myogenesis and increased apoptosis in myotonic dystrophy type 1 muscle cells. Cell death differs. https://doi.org/10.1038/cdd.2010.33 (2010).

    Google Scholar article

  • Hughet, A. et al. Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats of the human DM1 locus. PLoS Genet. 8e1003043 (2012).

    Google Scholar article

  • Morriss, GR, Rajapakshe, K., Huang, S., Coarfa, C. & Cooper, TA Mechanisms of skeletal muscle wasting in a mouse model of myotonic dystrophy type 1. Hmm. Mol. Broom. 272789-2804 (2018).

    Google Scholar article

  • Brochoff, M. et al. Targeting dysregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I. J. Clin. Invest. 127549-563 (2017).

    Google Scholar article

  • Jenquin, JR et al. Furamidine rescues myotonic dystrophy type I associated with poor splicing by multiple mechanisms. ACS Chem. Biol. 132708-2718 (2018).

    Google Scholar article

  • Bisset, Dominican Republic et al. Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy. Hmm. Mol. Broom. 244971-4983 (2015).

    Google Scholar article

  • Strike, T. et al. Regional variation in thigh muscle fat infiltration in patients with neuromuscular diseases compared to healthy controls. As to. Med Imaging. Surg. 112610-2621 (2021).

    Google Scholar article

  • Yushkevich, Pennsylvania et al. Active user-guided 3D contour segmentation of anatomical structures: Significantly improved efficiency and reliability. Neuroimaging 311116-1128 (2006).

    Google Scholar article

  • Otsu, N. A method of threshold selection from grayscale histograms. IEEE Trans. System Cybern Man. 962–66 (1979).

    Google Scholar article

  • [ad_2]

    Leave a Reply

    Your email address will not be published. Required fields are marked *